Abstract
A radiopharmaceutical is a radioactive compound used for the diagnosis and therapeutic treatment of human diseases. In nuclear medicine nearly 95% of the radiopharmaceuticals are used for diagnostic purposes, while the rest are used for therapeutic treatment. Radiopharmaceuticals usually have no pharmacologic effect, because in most cases they are used in tracer quantities. In these cases, they do not show any dose—response relationship and thus differ from conventional drugs. Because they are administered to humans, they should be sterile and pyrogen free, and they should undergo all quality control measures required of a conventional drug. A radiopharmaceutical may be a radioactive element such as 133Xe, or a labeled compound such as 131I-iodinated proteins and 99mTc-labeled compounds.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Suggested Reading
Billinghurst MW, Rempel S, Westendorf BA. Radiation decomposition of techne-tium-99m radiopharmaceuticals. J Nucl Med. 1979; 20:138.
Clark MJ, Podbielski L. Medical diagnostic imaging with complexes of Tc-99m. Coord Chem Rev. 1987; 78:253.
Deutsch E, Nicolini M, Wagner HN, Jr eds. Technetium in Chemistry and Nuclear Medicine. Verona: Cortina International; 1983.
Dewanjee MK. The chemistry of 99mTc-labeled radiopharmaceuticals. Semin Nucl Med. 1990; 20:5.
Dewanjee MK. Radioiodination: Theory, Practice and Biomedical Application. Boston: Kluwer Academic; 1992
Eckelman WC, Coursey BM, eds. Technetium-99m. Int J Appl Radiat hot. 1982; 33:843.
Eckelman WC, Steigman J, Paik CH. Radiopharmaceutical chemistry. In: Harpert J, Eckelman WC, Neumann RD, eds. Nuclear Medicine: Diagnosis and Therapy. New York: Thieme Medical; 1996:213.
Jones AG, Davison A. The chemistry of Tc(I), II, III, IV. Int J Appl Radiat Isot. 1982a; 33:867.
Jones AG, Davison A. The relevance of basic technetium chemistry to nuclear medicine. J Nucl Med. 1982b; 23:1041.
Kotegov KV, Pavlov ON, Shvedov VP. Technetium. In: Advances in Inorganic Chemistry and Radiochemistry. New York: Academic Press; 1968:2.
Lathrop KA, Harper PV, Rich BH, et al. Rapid incorporation of short-lived cyclotron produced radionuclides into radiopharmaceuticals. In Radiopharmaceuticals and Labeled Compounds. Vienna: IAEA; 1973: 471.
Nicolini M, Bandoli G, Mazzi U, eds. Technetium in Chemistry and Nuclear Medicine. Verona: Cortina International; 1986.
Richards P, Steigman J. Chemistry of technetium as applied to radiopharmaceuticals. In: Subramanian G, Rhodes BA, Cooper JF, Sodd VJ, eds. Radiopharmaceuticals. New York: Society of Nuclear Medicine; 1975:23.
Srivastava SC, Meinken G, Smith TD, Richards P. Problems associated with stannous 99mTc-radiopharmaceutical. In: Welch MJ, ed. Radiopharmaceuticals and Other Compounds Labelled with Short-Lived Radionuclides. New York: Pergamon Press; 1977:83.
Steigman J, Eckelman WC. The Chemistry of Technetium in Medicine. Nuclear Medicine Series. NAS-NS-3204. Washington: National Head Press; 1992.
Wilbur DS, Hadley SW, Hylarides MD, et al. Development of a stable radio-iodinating reagent to label monoclonal antibodies for radiotherapy of cancer. J Nucl Med. 1989; 30:216.
Yalow RS, Berson SA. Labeling of proteins—Problems and practices. NY Acad Sci. 1966; 28:1033.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Saha, G.B. (1998). Radiopharmaceuticals and Methods of Radiolabeling. In: Fundamentals of Nuclear Pharmacy. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-2934-4_6
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2934-4_6
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-2936-8
Online ISBN: 978-1-4757-2934-4
eBook Packages: Springer Book Archive